These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Oral contraceptives and cardiovascular complications]. Murad V Arq Bras Cardiol; 1983 Mar; 40(3):215-21. PubMed ID: 6360098 [No Abstract] [Full Text] [Related]
23. [Effect of oral contraceptives on the circulatory system]. Stasiński T; Lehmann Z; Kostka-Wach M; Biryńczyk J; Warenik-Szymankiewicz A Pol Tyg Lek; 1980 May; 35(19):713-5. PubMed ID: 6997842 [No Abstract] [Full Text] [Related]
24. [Myocardial infarct in young women--is it related to oral contraceptives?]. Böttiger LE; Westerholm B Lakartidningen; 1972 Aug; 69(32):3649-52. PubMed ID: 5070377 [No Abstract] [Full Text] [Related]
25. Thromboembolic complications of pregnancy and oral contraceptives. Handin RI Prog Cardiovasc Dis; 1974; 16(4):395-405. PubMed ID: 4589897 [No Abstract] [Full Text] [Related]
27. Oral contraceptives and the risk of myocardial infarction. Hannaford P N Engl J Med; 2002 Jun; 346(23):1826-9; author reply 1826-9. PubMed ID: 12050347 [No Abstract] [Full Text] [Related]
28. [Estrogens and cardiovascular diseases: should current guidelines be changed?]. Beller F; Theiss W Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812 [TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: state-of-the-art. World Health Organization. Helmerhorst FM; Rosendaal FR; Vandenbroucke JP Hum Reprod; 1998 Nov; 13(11):2981-3. PubMed ID: 9853839 [No Abstract] [Full Text] [Related]
31. Letter: Oral contraceptives and myocardial infarction. Susens GP N Engl J Med; 1975 Oct; 293(18):938. PubMed ID: 1177995 [No Abstract] [Full Text] [Related]
33. Recurrent stroke associated with the use of synthetic steroids. Case report. Somers J Mo Med; 1967 Aug; 64(8):717-9. PubMed ID: 6045799 [No Abstract] [Full Text] [Related]
34. Systemic effects of oral contraceptives. Kelly TM West J Med; 1984 Jul; 141(1):113-6. PubMed ID: 6089441 [TBL] [Abstract][Full Text] [Related]
35. [Major vascular complications during treatment with oral contraceptives and retrospective discovery of idiopathic hyperlipemia. 9 cases]. de Gennes JL; Turpin G; Truffert J Presse Med (1893); 1970 Mar; 78(12):541-6. PubMed ID: 5439189 [No Abstract] [Full Text] [Related]
36. Female sex hormones and thrombosis. Epidemiological aspects. Vessey MP; Mann JI Br Med Bull; 1978 May; 34(2):157-62. PubMed ID: 350339 [No Abstract] [Full Text] [Related]
37. [Against continuing oral contraceptives up to age 50]. Haramburu F Gynecol Obstet Fertil; 2005 Mar; 33(3):166-8. PubMed ID: 15848093 [No Abstract] [Full Text] [Related]
39. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
40. [Should the use of oral contraceptives be stopped by the age of 40?]. Halttunen M Duodecim; 2002; 118(16):1629-30. PubMed ID: 12271939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]